- Anika Therapeutics ( NASDAQ: ANIK ) is scheduled to announce Q2 earnings results on Wednesday, August 3rd, after market close.
- The consensus EPS Estimate is -$0.21 (-333.3% Y/Y) and the consensus Revenue Estimate is $37.85M (-0.7% Y/Y).
- Over the last 2 years, ANIK has beaten EPS estimates 88% of the time and has beaten revenue estimates 88% of the time.
- Over the last 3 months, EPS estimates have seen 1 upward revision and 1 downward. Revenue estimates have seen 0 upward revisions and 2 downward.
For further details see:
Anika Therapeutics Q2 2022 Earnings Preview